Week in Review for BXT, ACTC an Geron

Geron started the week at $1.47 a share and ended at $1.13. Thanks to the earnings call on March 13th, no new trials till 2014 or 2015 and that's only if results are good for the last trial ending some time this year. Also it was reported that Chip the CEO made $450 an hour assuming a 40 hour week. I think that's a little high for this year looks like a waste of time and money.....ACTC still around 7 cents had good news. Initiate treatment of third patient cohort in all three clinical trials. I feel ACTC will made it big, but with my track record it's like hoping a blind squirrel finds a nut. BTX started the week at $4.14 and closed Friday at $4.41 all on light volume. I like this company to. Time will tell if they will make it big. Good luck in this rigged casino.

ACTC the future in bio-tech: BTX, ACTC, Geron week in review

ACTC the future in bio-tech: BTX, ACTC, Geron week in review: ACTC announced fourth quarter and year end results March 7th. Nothing said that moved the stock price. Still at 7 cents. Need money, results...

BTX, ACTC, Geron week in review

ACTC announced fourth quarter and year end results March 7th. Nothing said that moved the stock price. Still at 7 cents. Need money, results and partner. BTX closed Monday at $3.96 and closed Friday at $4.17 volume was light. Needs results, need to make money. Geron will announce financial results for the 4th quarter March 12th. I hope for good news, like they lost less money. Its just a waiting game, if they can last, and have good results on there trials, then the stock price will soar. If the money runs out first, zero share price. Good luck in this rigged casino.